Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 6Sarcoma 4Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 17Ovarian Neoplasms 4Sarcoma 3Pancreatic Neoplasms 3Neoplasms 3Melanoma 3Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Neoplasm Metastasis 2Lung Neoplasms 2Head and Neck Neoplasms 2Gastrointestinal Neoplasms 2Breast Neoplasms, Male 2Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor - Protocol Specific 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1Hypertension 1Glioblastoma 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1

Interventions

pembrolizumab 3fludarabine 2Paclitaxel 2Gemcitabine 2Cyclophosphamide 2Azacitidine 2vocimagene amiretrorepvec 1temsirolimus 1spartalizumab 1sonidegib 1sacituzumab govitecan 1ruxolitinib 1rucaparib 1ridaforolimus 1pazopanib 1motexafin gadolinium 1lenvatinib 1durvalumab 1depatuxizumab mafodotin 1cediranib 1cc-486 1carboxyamido-triazole 1abiraterone 1Thalidomide 1Temozolomide 1Sorafenib 1Sirolimus 1Radiation 1Quality of Life 1Proton Pump Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioblastoma × pazopanib × Breast × Clear all
NCT01392352 2020-02-13

HYPAZ

Cambridge University Hospitals NHS Foundation Trust

Phase 2 Terminated
31 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Gastrointestinal Neoplasms, Glioblastoma, Hypertension, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡